BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zou M, Liu Y, Xie S, Wang L, Li D, Li L, Wang F, Zhang Y, Xia W, Sun C, Wu L. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. Open Biol 2021;11:200306. [PMID: 33529552 DOI: 10.1098/rsob.200306] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Kim UJ, Hong N, Ahn JC. Photobiomodulation Attenuated Cognitive Dysfunction and Neuroinflammation in a Prenatal Valproic Acid-Induced Autism Spectrum Disorder Mouse Model. Int J Mol Sci 2022;23. [PMID: 36555737 DOI: 10.3390/ijms232416099] [Reference Citation Analysis]
2 Raz N, Heller I, Lombardi T, Marino G, Davidson EM, Eyal AM. Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.979403] [Reference Citation Analysis]
3 Yui K, Imataka G, Yoshihara S. Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder. IJMS 2022;23:9803. [DOI: 10.3390/ijms23179803] [Reference Citation Analysis]
4 Warren WG, Hale E, Papagianni EP, Cassaday HJ, Stevenson CW, Stubbendorff C. URB597 induces subtle changes to aggression in adult Lister Hooded rats. Front Psychiatry 2022;13:885146. [DOI: 10.3389/fpsyt.2022.885146] [Reference Citation Analysis]
5 Sainz-Cort A, Jimenez-Garrido D, Muñoz-Marron E, Viejo-Sobera R, Heeroma J, Bouso JC. The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study. Cannabis Cannabinoid Res 2022. [PMID: 35881851 DOI: 10.1089/can.2022.0037] [Reference Citation Analysis]
6 Schnapp A, Harel M, Cayam-rand D, Cassuto H, Polyansky L, Aran A. A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ. Biomedicines 2022;10:1685. [DOI: 10.3390/biomedicines10071685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Coccurello R, Marrone MC, Maccarrone M. The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders. Front Pharmacol 2022;13:869606. [DOI: 10.3389/fphar.2022.869606] [Reference Citation Analysis]
8 Navarro D, Gasparyan A, Navarrete F, Torregrosa AB, Rubio G, Marín-Mayor M, Acosta GB, Garcia-Gutiérrez MS, Manzanares J. Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders. Int J Mol Sci 2022;23:4764. [PMID: 35563156 DOI: 10.3390/ijms23094764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Carreira LD, Matias FC, Campos MG. Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders. Biomedicines 2022;10:796. [DOI: 10.3390/biomedicines10040796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Warren WG, Hale E, Papagianni EP, Cassaday HJ, Stevenson CW, Stubbendorff C. URB597 induces aggression in adult Lister Hooded rats.. [DOI: 10.1101/2022.03.09.483601] [Reference Citation Analysis]
11 Sato A, Kotajima-murakami H, Tanaka M, Katoh Y, Ikeda K. Influence of Prenatal Drug Exposure, Maternal Inflammation, and Parental Aging on the Development of Autism Spectrum Disorder. Front Psychiatry 2022;13:821455. [DOI: 10.3389/fpsyt.2022.821455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ferhat A, Biton A, Verpy E, Forget B, de Chaumont F, Mueller F, Le Sourd A, Coqueran S, Schmitt J, Rochefort C, Rondi-reig L, Leboucher A, Boland A, Fin B, Deleuze JF, Boeckers TM, Ey E, Bourgeron T. Excessive self-grooming of Shank3 mutant mice is associated with gene dysregulation and imbalance between the striosome and matrix compartments in the striatum.. [DOI: 10.1101/2022.01.19.476922] [Reference Citation Analysis]
13 De Pol M, Kolla NJ. Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies. Psychiatry Res 2021;306:114256. [PMID: 34775294 DOI: 10.1016/j.psychres.2021.114256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Thornton AM, Humphrey RM, Kerr DM, Finn DP, Roche M. Increasing Endocannabinoid Tone Alters Anxiety-Like and Stress Coping Behaviour in Female Rats Prenatally Exposed to Valproic Acid. Molecules 2021;26:3720. [PMID: 34207178 DOI: 10.3390/molecules26123720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Zamberletti E, Rubino T, Parolaro D. Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder. Pharmacol Ther 2021;226:107878. [PMID: 33895189 DOI: 10.1016/j.pharmthera.2021.107878] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]